9
Blood pressure control: Where do we stand? Latest data from Italy Tocci G et al. J Hypertens. 2012;30:1065- 1074.

Blood pressure control: Where do we stand? Latest data from Italy Tocci G et al. J Hypertens. 2012;30:1065-1074

Embed Size (px)

DESCRIPTION

A developed country case: Italy Analysis of the largest, representative and updated sample of hypertensive patients in Italy From the most recent observational studies available over the last 5 years ( ) – hypertensive patients – Mean age 56.6 years, 60% women, BMI 27.2 – Mostly in general practice Tocci G et al. J Hypertens. 2012;30:

Citation preview

Page 1: Blood pressure control: Where do we stand? Latest data from Italy Tocci G et al. J Hypertens. 2012;30:1065-1074

Blood pressure control: Where do we stand?

Latest data from Italy

Tocci G et al. J Hypertens. 2012;30:1065-1074.

Page 2: Blood pressure control: Where do we stand? Latest data from Italy Tocci G et al. J Hypertens. 2012;30:1065-1074

Hypertension still the biggest issue

• 1.56 billion hypertensive patients in the world in 20251

• 20 million new cases of hypertension per year1

• High blood pressure is the first cause of death and burden around the world2

1. Kearney et al. Lancet. 2005; 365:217-223.2. Ezzati et al. N Engl J Med. 2013;369:954-964.

Page 3: Blood pressure control: Where do we stand? Latest data from Italy Tocci G et al. J Hypertens. 2012;30:1065-1074

A developed country case: Italy

• Analysis of the largest, representative and updated sample of hypertensive patients in Italy

• From the most recent observational studies available over the last 5 years (2005-2011)– 158 876 hypertensive patients– Mean age 56.6 years, 60% women, BMI 27.2– Mostly in general practice

Tocci G et al. J Hypertens. 2012;30:1065-1074.

Page 4: Blood pressure control: Where do we stand? Latest data from Italy Tocci G et al. J Hypertens. 2012;30:1065-1074

Only 57% of the hypertensive population is treated

Tocci G et al. J Hypertens. 2012;30:1065-1074.

Page 5: Blood pressure control: Where do we stand? Latest data from Italy Tocci G et al. J Hypertens. 2012;30:1065-1074

37% of the treated hypertensive population have controlled blood pressure

Tocci G et al. J Hypertens. 2012;30:1065-1074.

Page 6: Blood pressure control: Where do we stand? Latest data from Italy Tocci G et al. J Hypertens. 2012;30:1065-1074

Evolution of hypertension management between 1999 and 2011

In 1999 In 2011

19% treated and controlled patients

37%treated and controlled patients

GPs 154.1/90.9 mm Hg 143.5/84.8 mm Hg

Specialists 147.2/89.6 mm Hg 146.5/88.5 mm Hg

SBP/DBP SBP/DBP

Tocci G. et al. J Hypertens. 2012;30:1065-1074.

Page 7: Blood pressure control: Where do we stand? Latest data from Italy Tocci G et al. J Hypertens. 2012;30:1065-1074

More than 70% of the hypertensive population have grade 1 hypertension

Tocci G et al. J Hypertens. 2012;30:1065-1074.

Blood pressure stratification among the studied population (treated or untreated)

Page 8: Blood pressure control: Where do we stand? Latest data from Italy Tocci G et al. J Hypertens. 2012;30:1065-1074

The French example: the majority of untreated patients have grade 1 hypertension

Lang T et al. Hypertension. 2001;38:449-454.

Blood pressure stratification in untreated hypertensive people in a working population, in France.

Page 9: Blood pressure control: Where do we stand? Latest data from Italy Tocci G et al. J Hypertens. 2012;30:1065-1074

Conclusion• Despite hypertension management improvement since 1999,1

hypertension is the 1st risk factor for cardiovascular disease.2

• 1 out 3 deaths is due to cardiovascular disease (2007).3

• The Italian case shows an inadequate control of blood pressure in a developed country. 1

• Only 37% of treated patients are controlled.1

• International guidelines advise controlling blood pressure below 140/90 mm Hg.4

• Most uncontrolled treated patients have grade 1 hypertension.5

• Each increase of 20/10 mm Hg (SBP/DBP) doubles the risk of cardiovascular death.6

1. Tocci G et al. J Hypertens. 2012;30:1065-1074.2. Hobbs, Richard FD. Vasc Health Risk Manag. 2007;3:711-719.3. Roger VL et al. Circulation. 2011;123:e18-e209. 4. Mancia G et al. Eur Heart J. 2013;34:2159-2219.5. Lang T et al. Hypertension. 2001;38:449-454. 6. Lewington S et al; Prospective Studies Collaboration. Lancet. 2002;360:1903-1913.